Anupam Banerjee

Dr. Anupam Banerjee

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
YZYueming Zhu
Yueming Zhu
ABAnupam Banerjee
Anupam Banerjee
PXPing Xie
Ping Xie
AIAndrei Ivanov
Andrei Ivanov
AUAmad Uddin
Amad Uddin
YWYong Wan
Yong Wan
Despite widespread utilization of immunotherapy, treating immune-cold tumors remains a challenge. Multiomic analyses and experimental validation identified the OTUD4/CD73 proteolytic axis as a promising target in treating immune-suppressive triple negative breast cancer (TNBC). Mechanistically, deubiquitylation of CD73 by OTUD4 counteracted its ubiquitylation by TRIM21, resulting in CD73 stabilization inhibiting tumor immune responses. We further demonstrated the importance of TGF-β signaling for orchestrating the OTUD4/CD73 proteolytic axis within tumor cells. Spatial transcriptomics profiling discovered spatially resolved features of interacting malignant and immune cells pertaining to expression levels of OTUD4 and CD73. In addition, ST80, a newly developed inhibitor, specifically disrupted proteolytic interaction between CD73 and OTUD4, leading to reinvigoration of cytotoxic CD8 + T cell activities. In preclinical models of TNBC, ST80 treatment sensitized refractory tumors to anti-PD-L1 therapy. Collectively, our findings uncover what we believe to be a novel strategy for targeting the immunosuppressive OTUD4/CD73 proteolytic axis in treating immune-suppressive breast cancers with the inhibitor ST80.

25 March 2017 in Multimedia Tools and Applications
Verified
Journal Article
Closed access
PDF file
ABAnupam Banerjee
Anupam Banerjee
SBSumana Basu
Sumana Basu
SBSubhadip Basu
Subhadip Basu
MNMita Nasipuri
Mita Nasipuri

1 July 2019 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
YRYetirajam Rajesh
Yetirajam Rajesh
ABAnupam Banerjee
Anupam Banerjee
IPIpsita Pal
Ipsita Pal
ABAngana Biswas
Angana Biswas
SDSubhayan Das
Subhayan Das
MMMahitosh Mandal
Mahitosh Mandal


2 May 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ABAnupam Banerjee
Anupam Banerjee
ABAnthony T. Bogetti
Anthony T. Bogetti
IBIvet Bahar
Ivet Bahar
Understanding the effects of missense mutations or single amino acid variants (SAVs) on protein function is crucial for elucidating the molecular basis of diseases/disorders and designing rational therapies. We introduce here Rhapsody-2 , a machine learning tool for discriminating pathogenic and neutral SAVs, significantly expanding on a precursor limited by the availability of structural data. With the advent of AlphaFold2 as a powerful tool for structure prediction, Rhapsody-2 is trained on a significantly expanded dataset of 117,525 SAVs corresponding to 12,094 human proteins reported in the ClinVar database. Adopting a broad set of descriptors composed of sequence evolutionary, structural, dynamic, and energetics features in the training algorithm, Rhapsody-2 achieved an AUROC of 0.94 in 10-fold cross-validation when all SAVs of a particular test protein (mutant) were excluded from the training set. Benchmarking against a variety of testing datasets demonstrated the high performance of Rhapsody-2 . While sequence evolutionary descriptors play a dominant role in pathogenicity prediction, those based on structural dynamics provide a mechanistic interpretation. Notably, residues involved in allosteric communication and those distinguished by pronounced fluctuations in the high-frequency modes of motion or subject to spatial constraints in soft modes usually give rise to pathogenicity when mutated. Overall, Rhapsody-2 provides an efficient and transparent tool for accurately predicting the pathogenicity of SAVs and unraveling the mechanistic basis of the observed behavior, thus advancing our understanding of genotype-to-phenotype relations.

31 May 2024 in Science Advances
Verified
Journal Article
Open access
ABAnupam Banerjee
Anupam Banerjee
SMSamuel Mathew
Samuel Mathew
MNMohsin M. Naqvi
Mohsin M. Naqvi
SYSema Z. Yilmaz
Sema Z. Yilmaz
MZMaria Zacharopoulou
Maria Zacharopoulou
IBIvet Bahar
Ivet Bahar
PR65 is the HEAT repeat scaffold subunit of the heterotrimeric protein phosphatase 2A (PP2A) and an archetypal tandem repeat protein. Its conformational mechanics plays a crucial role in PP2A function by opening/closing substrate binding/catalysis interface. Using in silico saturation mutagenesis, we identified PR65 “hinge” residues whose substitutions could alter its conformational adaptability and thereby PP2A function, and selected six mutations that were verified to be expressed and soluble. Molecular simulations and nanoaperture optical tweezers revealed consistent results on the specific effects of the mutations on the structure and dynamics of PR65. Two mutants observed in simulations to stabilize extended/open conformations exhibited higher corner frequencies and lower translational scattering in experiments, indicating a shift toward extended conformations, whereas another displayed the opposite features, confirmed by both simulations and experiments. The study highlights the power of single-molecule nanoaperture-based tweezers integrated with in silico approaches for exploring the effect of mutations on protein structure and dynamics.